Randomisation
ONCOLOGY
Participants were randomised when they had completed the informed consent and baseline questionnaire. Participants were stratified by participating site and the patient’s Eastern Cooperative Oncology Group (ECOG) score (0–1 or ≥ 2) to ensure an even distribution between arms was achieved.Block randomisation to treatment arm within each stratification was carried out using a computer-generated randomised table. Allocation to the treatment arms was centralised with the principal investigator at Curtin University allocating participants to trial arms after informed consent and baseline data collection. This method ensured the nurses/research assistants who had initial contact with the patients/carers and responsible for data collection were not involved in allocating participants to trial arms. Individual participants were informed of their allocated treatment arm; blinding was not possible due to the nature of the intervention.